Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment

Key Points

• Immune response is significantly influenced by the timing of SARS-CoV-2 vaccination during cladribine treatment.
• Patients exhibited varied immune responses based on vaccination dynamics, particularly during the treatment period.
• Analysis focuses on individuals with multiple sclerosis undergoing cladribine therapy, capturing vaccination effects on immunity.
• Further exploration is needed to optimize vaccination protocols for immunocompromised populations, especially those on cladribine.